Search
Products
Community
Markets
News
Brokers
More
EN
Get started
Markets
/
Taiwan
/
ETF market
/
00898
/
Analysis
CATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REV
00898
Taiwan Stock Exchange
00898
Taiwan Stock Exchange
00898
Taiwan Stock Exchange
00898
Taiwan Stock Exchange
Market closed
Market closed
No trades
See on Supercharts
Overview
Analysis
Discussions
Technicals
Seasonals
Key stats
Assets under management (AUM)
1.72 B
TWD
Fund flows (1Y)
−595.46 M
TWD
Dividend yield (indicated)
—
Discount/Premium to NAV
−0.1%
About CATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REV
Issuer
Cathay Financial Holdings Co., Ltd.
Brand
Cathay
Expense ratio
1.05%
Home page
cathaysite.com.tw
Inception date
Nov 22, 2021
Index tracked
Solactive Global Genomics Immunology and Medical Revolution Index - Benchmark TR Net
Management style
Passive
ISIN
TW0000089804
1 90%() 2 1 () 100%
Show more
Classification
Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Health care equipment & services
Strategy
Vanilla
Weighting scheme
Market cap
Selection criteria
Market cap
Returns
1 month
3 months
Year to date
1 year
3 years
5 years
Price performance
—
—
—
—
—
—
NAV total return
—
—
—
—
—
—
What's in the fund
As of November 12, 2024
Exposure type
Stocks
Bonds, Cash & Other
Health Technology
Stocks
99.54%
Health Technology
97.93%
Health Services
1.61%
Bonds, Cash & Other
0.46%
Cash
0.46%
Stock breakdown by region
84%
11%
4%
North America
84.29%
Europe
11.39%
Asia
4.31%
Latin America
0.00%
Africa
0.00%
Middle East
0.00%
Oceania
0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows